is there oral glp 1 FDA approves Foundayo, an GLP-1 alternative to Wegovy and Ozempic Novel oral GLP-1 receptor agonist

We're a small business and pride ourselves in quality products and support!

Harvard geneticist David Sinclair reveals a rare but serious blindness risk linked to GLP-1 drugs, estimating 20,00030,000 NAION cases per year in

Medicaid Services proposed to expand Medicare Part D and Medicaid to cover weight loss drugs

Pantry snack staples

In a survey, employers told the Business Group on Health that they arent yet seeing evidence of long-term health benefits from taking GLP-1s for weight loss, leaving them unsure how to manage costs while continuing to cover them.

GLP-2 (Tirzepatide) is a dual incretin receptor agonist widely utilized in preclinical research involving metabolic regulation, incretin signaling, and energy balance-associated biochemical pathways